149 related articles for article (PubMed ID: 23486070)
1. Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy?
Huchko MJ; Woo V; Liegler T; Leddy A; Smith-McCune K; Sawaya GF; Bukusi EA; Cohen CR
J Low Genit Tract Dis; 2013 Jul; 17(3):354-60. PubMed ID: 23486070
[TBL] [Abstract][Full Text] [Related]
2. Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy.
Woo VG; Liegler T; Cohen CR; Sawaya GF; Smith-McCune K; Bukusi EA; Huchko MJ
AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1000-5. PubMed ID: 23594240
[TBL] [Abstract][Full Text] [Related]
3. Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study.
Huchko MJ; Woo VG; Liegler T; Leslie H; Smith-McCune K; Sawaya GF; Bukusi EA; Cohen CR
BJOG; 2013 Sep; 120(10):1233-9. PubMed ID: 23647852
[TBL] [Abstract][Full Text] [Related]
4. Cervical intraepithelial neoplasia and cervicovaginal shedding of human immunodeficiency virus.
Spinillo A; Zara F; Gardella B; Preti E; Gaia G; Maserati R
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):314-20. PubMed ID: 16449118
[TBL] [Abstract][Full Text] [Related]
5. Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy.
Gitau RW; Graham SM; Masese LN; Overbaugh J; Chohan V; Peshu N; Richardson BA; Jaoko W; Ndinya-Achola JO; McClelland RS
AIDS; 2010 Nov; 24(17):2733-7. PubMed ID: 20871388
[TBL] [Abstract][Full Text] [Related]
6. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.
Minkoff H; Ahdieh L; Massad LS; Anastos K; Watts DH; Melnick S; Muderspach L; Burk R; Palefsky J
AIDS; 2001 Nov; 15(16):2157-64. PubMed ID: 11684935
[TBL] [Abstract][Full Text] [Related]
7. Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.
Neely MN; Benning L; Xu J; Strickler HD; Greenblatt RM; Minkoff H; Young M; Bremer J; Levine AM; Kovacs A
J Acquir Immune Defic Syndr; 2007 Jan; 44(1):38-42. PubMed ID: 17106279
[TBL] [Abstract][Full Text] [Related]
8. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy.
Palefsky JM
Curr Opin Oncol; 2003 Sep; 15(5):382-8. PubMed ID: 12960521
[TBL] [Abstract][Full Text] [Related]
9. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.
Graham SM; Holte SE; Peshu NM; Richardson BA; Panteleeff DD; Jaoko WG; Ndinya-Achola JO; Mandaliya KN; Overbaugh JM; McClelland RS
AIDS; 2007 Feb; 21(4):501-7. PubMed ID: 17301569
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina Faso.
Nagot N; Ouedraogo A; Weiss HA; Konate I; Sanon A; Defer MC; Sawadogo A; Andonaba JB; Vallo R; Becquart P; Segondy M; Mayaud P; Van de Perre P;
Sex Transm Infect; 2008 Jun; 84(3):167-70. PubMed ID: 18055582
[TBL] [Abstract][Full Text] [Related]
11. Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy.
Graham SM; Masese L; Gitau R; Richardson BA; Mandaliya K; Peshu N; Jaoko W; Ndinya-Achola J; Overbaugh J; McClelland RS
Sex Transm Infect; 2011 Mar; 87(2):114-7. PubMed ID: 20980464
[TBL] [Abstract][Full Text] [Related]
12. The impact of syndromic treatment of sexually transmitted diseases on genital shedding of HIV-1.
Wolday D; Gebremariam Z; Mohammed Z; Dorigo-Zetsma W; Meles H; Messele T; Geyid A; Sanders E; Maayan S
AIDS; 2004 Mar; 18(5):781-5. PubMed ID: 15075513
[TBL] [Abstract][Full Text] [Related]
13. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.
Fiore JR; Suligoi B; Saracino A; Di Stefano M; Bugarini R; Lepera A; Favia A; Monno L; Angarano G; Pastore G
AIDS; 2003 Oct; 17(15):2169-76. PubMed ID: 14523273
[TBL] [Abstract][Full Text] [Related]
14. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.
Cu-Uvin S; Caliendo AM; Reinert S; Chang A; Juliano-Remollino C; Flanigan TP; Mayer KH; Carpenter CC
AIDS; 2000 Mar; 14(4):415-21. PubMed ID: 10770544
[TBL] [Abstract][Full Text] [Related]
15. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV.
Fontaine J; Hankins C; Mayrand MH; Lefevre J; Money D; Gagnon S; Rachlis A; Pourreaux K; Ferenczy A; Coutlée F;
AIDS; 2005 May; 19(8):785-94. PubMed ID: 15867492
[TBL] [Abstract][Full Text] [Related]
16. Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women.
Lehtovirta P; Paavonen J; Heikinheimo O
Int J STD AIDS; 2008 Jan; 19(1):37-41. PubMed ID: 18275645
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.
Mcclelland RS; Wang CC; Mandaliya K; Overbaugh J; Reiner MT; Panteleeff DD; Lavreys L; Ndinya-Achola J; Bwayo JJ; Kreiss JK
AIDS; 2001 Jan; 15(1):105-10. PubMed ID: 11192850
[TBL] [Abstract][Full Text] [Related]
18. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.
Homans J; Christensen S; Stiller T; Wang CH; Mack W; Anastos K; Minkoff H; Young M; Greenblatt R; Cohen M; Strickler H; Karim R; Spencer LY; Operskalski E; Frederick T; Kovacs A
J Acquir Immune Defic Syndr; 2012 May; 60(1):99-110. PubMed ID: 22517416
[TBL] [Abstract][Full Text] [Related]
19. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.
Blitz S; Baxter J; Raboud J; Walmsley S; Rachlis A; Smaill F; Ferenczy A; Coutlée F; Hankins C; Money D;
J Infect Dis; 2013 Aug; 208(3):454-62. PubMed ID: 23624362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]